QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
NASDAQ:DRIO

DarioHealth (DRIO) Stock Forecast, Price & News

$4.16
+0.15 (+3.74%)
(As of 06/5/2023 ET)
Compare
Today's Range
$3.88
$4.33
50-Day Range
$3.20
$4.16
52-Week Range
$3.13
$7.69
Volume
170,530 shs
Average Volume
150,635 shs
Market Capitalization
$109.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.40

DarioHealth MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
174.0% Upside
$11.40 Price Target
Short Interest
Bearish
7.74% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.87) to ($1.70) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.37 out of 5 stars

Medical Sector

945th out of 985 stocks

Surgical & Medical Instruments Industry

93rd out of 97 stocks


DRIO stock logo

About DarioHealth (NASDAQ:DRIO) Stock

DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in New York, NY.

Receive DRIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DarioHealth and its competitors with MarketBeat's FREE daily newsletter.

DRIO Stock News Headlines

Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
DarioHealth Q1 2023 Earnings Preview
LifeSci Capital Sticks to Their Buy Rating for DarioHealth (DRIO)
See More Headlines

DRIO Price History

DRIO Company Calendar

Last Earnings
3/09/2023
Today
6/05/2023
Next Earnings (Estimated)
8/21/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:DRIO
Employees
200
Year Founded
2011

Price Target and Rating

Average Stock Price Forecast
$11.40
High Stock Price Forecast
$15.00
Low Stock Price Forecast
$6.00
Forecasted Upside/Downside
+177.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-62,190,000.00
Net Margins
-125.46%
Pretax Margin
-221.65%

Debt

Sales & Book Value

Annual Sales
$27.66 million
Book Value
$3.12 per share

Miscellaneous

Free Float
23,883,000
Market Cap
$108.34 million
Optionable
Not Optionable
Beta
1.35

Social Links


Key Executives

  • Erez RaphaelErez Raphael
    Chief Executive Officer & Director
  • Richard Allen Anderson
    President & General Manager-North America Region
  • Joshua Fischer
    SVP-Operations & Compliance
  • Zvi Ben-David
    Chief Financial Officer, Secretary & Treasurer
  • Michal Hershkovitz
    Vice President-Clinical, Regulatory Affairs & QA













DRIO Stock - Frequently Asked Questions

Should I buy or sell DarioHealth stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DarioHealth in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" DRIO shares.
View DRIO analyst ratings
or view top-rated stocks.

What is DarioHealth's stock price forecast for 2023?

4 brokerages have issued 12-month price targets for DarioHealth's shares. Their DRIO share price forecasts range from $6.00 to $15.00. On average, they anticipate the company's stock price to reach $11.40 in the next twelve months. This suggests a possible upside of 177.4% from the stock's current price.
View analysts price targets for DRIO
or view top-rated stocks among Wall Street analysts.

How have DRIO shares performed in 2023?

DarioHealth's stock was trading at $4.28 at the beginning of the year. Since then, DRIO shares have decreased by 4.0% and is now trading at $4.11.
View the best growth stocks for 2023 here
.

Are investors shorting DarioHealth?

DarioHealth saw a increase in short interest in May. As of May 15th, there was short interest totaling 2,040,000 shares, an increase of 9.7% from the April 30th total of 1,860,000 shares. Based on an average daily trading volume, of 161,100 shares, the short-interest ratio is currently 12.7 days.
View DarioHealth's Short Interest
.

When is DarioHealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 21st 2023.
View our DRIO earnings forecast
.

How were DarioHealth's earnings last quarter?

DarioHealth Corp. (NASDAQ:DRIO) announced its quarterly earnings data on Thursday, March, 9th. The company reported ($0.51) earnings per share for the quarter, beating analysts' consensus estimates of ($0.60) by $0.09. The firm earned $6.81 million during the quarter, compared to analysts' expectations of $6.65 million. DarioHealth had a negative net margin of 125.46% and a negative trailing twelve-month return on equity of 39.28%. During the same period last year, the business posted ($1.09) earnings per share.

What other stocks do shareholders of DarioHealth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DarioHealth investors own include Aeterna Zentaris (AEZS), Vascular Biogenics (VBLT), Nano Dimension (NNDM), Pluristem Therapeutics (PSTI), NVIDIA (NVDA), AbbVie (ABBV), Gilead Sciences (GILD), ADMA Biologics (ADMA) and Avadel Pharmaceuticals (AVDL).

What is DarioHealth's stock symbol?

DarioHealth trades on the NASDAQ under the ticker symbol "DRIO."

Who are DarioHealth's major shareholders?

DarioHealth's stock is owned by many different institutional and retail investors. Top institutional investors include Appian Way Asset Management LP (3.88%), Perceptive Advisors LLC (1.19%), BlackRock Inc. (0.57%), MAI Capital Management (0.56%), Susquehanna International Group LLP (0.23%) and Renaissance Technologies LLC (0.22%). Insiders that own company stock include Dennis M Mcgrath, Dror Bacher, Erez Raphael and Oded Cohen.
View institutional ownership trends
.

How do I buy shares of DarioHealth?

Shares of DRIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DarioHealth's stock price today?

One share of DRIO stock can currently be purchased for approximately $4.11.

How much money does DarioHealth make?

DarioHealth (NASDAQ:DRIO) has a market capitalization of $108.34 million and generates $27.66 million in revenue each year. The company earns $-62,190,000.00 in net income (profit) each year or ($1.44) on an earnings per share basis.

How many employees does DarioHealth have?

The company employs 200 workers across the globe.

Does DarioHealth have any subsidiaries?
The following companies are subsidiares of DarioHealth: Labstyle Innovation Ltd., PsyInnovations Inc., PsyInnovations India Private Limited., Upright Technologies Inc., and Upright Technologies Ltd..
Read More
How can I contact DarioHealth?

DarioHealth's mailing address is 8 HaToKhen Street, Caesarea Industrial Park L3, 3088900. The official website for the company is www.mydario.com. The company can be reached via phone at (833) 914-3796, via email at ir@mydario.com, or via fax at 972-4770-4059.

This page (NASDAQ:DRIO) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -